What are the symptoms of myelodysplastic syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Myelodysplastic Syndrome

Myelodysplastic syndrome typically presents with symptoms related to blood cytopenias—most commonly anemia, neutropenia, and thrombocytopenia—rather than having hallmark symptoms specific to the disease itself. 1, 2, 3

Primary Clinical Manifestations

Anemia-Related Symptoms (Most Common)

  • Fatigue and weakness are the predominant presenting complaints, as almost all MDS patients develop anemia, usually macrocytic 1, 2
  • Dyspnea on exertion and reduced exercise tolerance 2
  • Pallor on physical examination 4
  • The anemia in MDS should never be dismissed as a "natural consequence of aging"—chronic unexplained anemia in elderly patients warrants investigation 3

Thrombocytopenia-Related Symptoms

  • Easy bruising and petechiae 2, 3
  • Mucosal bleeding (gums, nose) 2
  • Prolonged bleeding from minor cuts 3

Neutropenia-Related Symptoms

  • Recurrent or persistent infections due to impaired immune function 2, 3
  • Fever associated with infections 4

Systemic Symptoms

  • Increased inflammation beyond what cytopenias alone would explain 4
  • Profound fatigue that may be disproportionate to the degree of anemia 4

Key Clinical Context

Insidious Presentation

  • MDS lacks hallmark symptoms, making it a diagnostic challenge that requires high clinical suspicion 3
  • The presentation is typically insidious and gradual rather than acute 2, 5
  • Disease course ranges from mild symptoms over many years to rapid progression toward acute leukemia 4

When to Suspect MDS

Heightened suspicion is warranted in:

  • Elderly patients (median age 70 years) with unexplained cytopenias 1, 2
  • Persistent, unexplained macrocytic anemia after excluding nutritional deficiencies 6, 3
  • Pancytopenia or bicytopenia of unclear etiology 3
  • Patients with prior chemotherapy exposure (especially alkylating agents, purine analogues) 1, 6
  • Previous radiotherapy or ionizing radiation exposure 1, 6
  • Occupational benzene exposure or agricultural/industrial work 1, 6
  • Current or past tobacco smoking 6
  • Family history of MDS, AML, or aplastic anemia, particularly in younger patients 6

Laboratory Clues in Peripheral Blood

Beyond cytopenias, specific morphologic abnormalities suggest MDS:

  • Anisocytosis and poikilocytosis (marked variation in red cell size and shape) 6
  • Basophilic stippling of red blood cells 6
  • Pseudo-Pelger-Huët neutrophils (abnormally hypolobulated nuclei) 6
  • Hypogranular neutrophils with reduced cytoplasmic granules 6
  • Circulating blasts in peripheral blood 6

Critical Diagnostic Caveat

Before diagnosing MDS, you must systematically exclude reversible causes of cytopenias:

  • Vitamin B12, folate, and iron deficiency 6
  • Viral infections (HIV, parvovirus B19, CMV, hepatitis B/C) 6
  • Medications causing marrow suppression 1, 6
  • Excessive alcohol consumption 1, 6
  • Autoimmune disorders 1
  • Renal failure 1
  • Paroxysmal nocturnal hemoglobinuria (PNH) 1, 6
  • Hereditary bone marrow failure syndromes (especially in younger patients with family history) 6

Approximately 1 in 6 patients with unexplained anemia may have findings compatible with MDS, suggesting this diagnosis should be considered earlier in the differential for persistent cytopenias in at-risk populations 3. Any patient with persistent, unexplained isolated cytopenia—particularly macrocytic anemia—should be referred to a hematologist for bone marrow evaluation 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Clinical Signs of Myelodysplastic Syndrome].

Therapeutische Umschau. Revue therapeutique, 2022

Guideline

Key Clinical Indicators and Risk Factors for Suspecting Myelodysplastic Syndromes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.